GUOFUHEE (02582) teams up with South Korean companies to develop hydrogen-powered electricity generation products targeting the American data center market.
Guo Fu Hydrogen (02582) announced on December 6, 2025, that the company has entered into a strategic cooperation agreement with BTE Inc. and Hylium Industries, Inc. (both companies established under the laws of the Republic of Korea) to collaborate on the development and manufacturing of natural gas reforming hydrogen proton exchange membrane power generation module products. Under the agreement, the product will consist of the natural gas reforming hydrogen equipment supplied by the company and the fuel cell power generation equipment supplied by BTE, and will be sold to US data centers through Hylium's wholly-owned subsidiary in the United States.
GUOFUHEE (02582) announced that on December 6, 2025, the company entered into a strategic cooperation agreement with BTE Inc. and Hylium Industries, Inc. (both companies established under the laws of the Republic of Korea) to collaborate on the development and manufacture of natural gas reforming hydrogen proton exchange membrane fuel cell modules. Under the agreement, the product will consist of natural gas reforming hydrogen equipment supplied by the company and fuel cell power generation equipment supplied by BTE, and will be sold through Hylium's wholly-owned subsidiary in the United States to data centers.
Based on the market demand resulting from power shortages in US data centers, the board believes that the product has significant market potential, aiming to secure orders of at least 1GW within three years, leveraging BTE's existing power supply demonstration projects in the United States to drive future revenue growth.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






